Elevance Health (ELV)

Total Assets

$126.44B

Quarterly · Period ending: · USD

ELV logo

ELV Total Assets

Latest reported$126.44B
ELV Quarterly Total Assets ($6.09B → $126.44B)
High-resolution chart · PNG

ELV total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Elevance Health Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
126,438,000,000
125,827,000,000
121,494,000,000
122,749,000,000
121,938,000,000
119,717,000,000
116,889,000,000
116,533,000,000
112,988,000,000
111,894,000,000
108,928,000,000
110,478,000,000
109,168,000,000
109,040,000,000
102,755,000,000
103,026,000,000
100,877,000,000
100,486,000,000
97,460,000,000
98,060,000,000
96,097,000,000
95,683,000,000
88,276,000,000
86,574,000,000
87,976,000,000
82,399,000,000
78,254,000,000
77,809,000,000
75,851,000,000
74,523,000,000
72,470,000,000
74,445,000,000
74,367,400,000
73,300,400,000
71,459,700,000
68,309,900,000
68,237,600,000
68,943,500,000
66,387,100,000
64,399,900,000
64,062,600,000
63,858,700,000
61,717,800,000
62,335,600,000
64,263,800,000
65,546,000,000
61,676,300,000
62,058,200,000
62,303,600,000
61,685,500,000
59,574,500,000
60,263,500,000
59,612,300,000
59,408,600,000
58,955,400,000
55,817,900,000
54,535,000,000
52,496,500,000
52,163,200,000
52,549,900,000
50,877,200,000
50,918,000,000
50,166,900,000
51,032,400,000
50,160,000,000
51,180,900,000
52,125,400,000
49,497,500,000
49,344,300,000
49,414,800,000
48,403,200,000
49,758,600,000
50,975,900,000
51,555,700,000
52,060,000,000
52,899,700,000
54,194,100,000
53,489,200,000
51,574,900,000
51,484,200,000
50,091,800,000
51,365,700,000
51,405,200,000
41,855,600,000
41,691,300,000
40,487,900,000
39,738,400,000
14,136,500,000
13,658,500,000
13,929,900,000
13,408,900,000
13,205,200,000
12,908,900,000
12,506,900,000
12,439,300,000
12,235,200,000
6,641,400,000
6,403,000,000
6,337,100,000
6,093,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.